STAT3 and familial pancreatic carcinoma: PG-S3-001 (Table 3), a small molecule derivative of the SH-4-54 class of STAT3 inhibitors, was found to have an antiproliferative effect on pancreatic cancer cells both in vivo and in vitro [99].